Abstract:This study aimed to estimate the disease burden and health-related quality of life (HRQOL) among patients with severe hand, foot, and mouth disease (HFMD) in Jiangsu Province, China. We analyzed the surveillance data of HFMD cases in Jiangsu Province from 2009 to 2020. Moreover, a cross-sectional study was conducted in Nanjing and Suzhou, China, between January 2017 and May 2018. Patients with severe HFMD and their parents were recruited from selected hospitals. Questionnaires and hospital management systems w… Show more
“…Several studies have explored the economic burden of HFMD patients in China [ 4 , 10 – 12 , 20 ]. Compared with the studies that included inpatients with worse conditions [ 4 , 10 , 20 ], in our study, lower average hospitalization and total costs were reported.…”
Section: Discussionmentioning
confidence: 99%
“…The three-level EuroQol-five dimensions (EQ-5D-3L) proxy 2 questionnaire [ 9 ] and TNO-AZL Preschool Quality of Life (TAPQOL) scale [ 10 ] were used to assess the health-related quality of life (HRQOL) of pediatric patients with HFMD. The results suggested that HFMD impaired the patients’ health in terms of both psychological and physical aspects [ 9 , 10 ], and thus reduced their HRQOL. However, few studies have used child-specific HRQOL instruments and compared health status changes before and after treatment.…”
Background
Hand, foot, and mouth disease (HFMD) is an infectious disease with high morbidity and mortality rates among children under 5 years old. This study aimed to explore the health-related quality of life (HRQOL), economic burden, and related influencing factors among Chinese HFMD patients.
Methods
From January to October 2019, a longitudinal cohort study of 296 hospitalized patients (≤ 5 years old) with HFMD and their guardians was conducted using the proxy version of the 5-level EQ-5D-Y (EQ-5D-Y-5L, Y-5L) in face-to-face interviews in Shanghai, Zhengzhou, and Kunming, representing three regions with different economic development levels. Multiple linear regression was used to explore the factors associated with HRQOL and costs.
Results
The mean Y-5L health utility score (HUS) (standard deviation, SD), and visual analogue scale (VAS) score (SD) were 0.730 (0.140) and 60.33 (16.52) at admission and increased to 0.920 (0.120) and 89.95 (11.88) at discharge, respectively. The children from Shanghai had the lowest HUSs at admission and had the best health improvement. The mean hospitalization cost and total cost were 4037 CNY and 5157 CNY, respectively. The children from Shanghai had the highest hospitalization cost (4559 CNY) and total cost (5491 CNY). Multiple regression analysis suggested that medical insurance status, type of employment, residence type, and religious status were significantly associated with the baseline HUS and improvement in the HUS after treatment. Region, loss of work time, and length of stay had a significant impact on the hospitalization cost and total cost.
Conclusion
Our findings demonstrate that HFMD could lead to poor HRQOL and the economic burden varies in different regions in China. Many pediatric patients still have physical or mental health problems shortly after treatment.
“…Several studies have explored the economic burden of HFMD patients in China [ 4 , 10 – 12 , 20 ]. Compared with the studies that included inpatients with worse conditions [ 4 , 10 , 20 ], in our study, lower average hospitalization and total costs were reported.…”
Section: Discussionmentioning
confidence: 99%
“…The three-level EuroQol-five dimensions (EQ-5D-3L) proxy 2 questionnaire [ 9 ] and TNO-AZL Preschool Quality of Life (TAPQOL) scale [ 10 ] were used to assess the health-related quality of life (HRQOL) of pediatric patients with HFMD. The results suggested that HFMD impaired the patients’ health in terms of both psychological and physical aspects [ 9 , 10 ], and thus reduced their HRQOL. However, few studies have used child-specific HRQOL instruments and compared health status changes before and after treatment.…”
Background
Hand, foot, and mouth disease (HFMD) is an infectious disease with high morbidity and mortality rates among children under 5 years old. This study aimed to explore the health-related quality of life (HRQOL), economic burden, and related influencing factors among Chinese HFMD patients.
Methods
From January to October 2019, a longitudinal cohort study of 296 hospitalized patients (≤ 5 years old) with HFMD and their guardians was conducted using the proxy version of the 5-level EQ-5D-Y (EQ-5D-Y-5L, Y-5L) in face-to-face interviews in Shanghai, Zhengzhou, and Kunming, representing three regions with different economic development levels. Multiple linear regression was used to explore the factors associated with HRQOL and costs.
Results
The mean Y-5L health utility score (HUS) (standard deviation, SD), and visual analogue scale (VAS) score (SD) were 0.730 (0.140) and 60.33 (16.52) at admission and increased to 0.920 (0.120) and 89.95 (11.88) at discharge, respectively. The children from Shanghai had the lowest HUSs at admission and had the best health improvement. The mean hospitalization cost and total cost were 4037 CNY and 5157 CNY, respectively. The children from Shanghai had the highest hospitalization cost (4559 CNY) and total cost (5491 CNY). Multiple regression analysis suggested that medical insurance status, type of employment, residence type, and religious status were significantly associated with the baseline HUS and improvement in the HUS after treatment. Region, loss of work time, and length of stay had a significant impact on the hospitalization cost and total cost.
Conclusion
Our findings demonstrate that HFMD could lead to poor HRQOL and the economic burden varies in different regions in China. Many pediatric patients still have physical or mental health problems shortly after treatment.
“…However, the current rate of EV-A71 vaccination still needed to be promoted, and Han et al. revealed that the overall vaccination rate for children in the birth cohort reached 19.63–28.63% from 2016 to 2019 in Jiangsu Province [ 36 ]. Although there is currently no licensed CV-A16 vaccine for use in humans, Sun et al.…”
“…12,17 and has been used to measure HRQoL in different pathologies, on occasions not specifying the psychometric properties of those populations. 10,13,[21][22][23][24][25][26][27] Given that the reliability and validity are not intrinsic properties of questionnaires, but depend on the target population of the measure, the purpose of this study was the psychometric assessment of the TAPQOL questionnaire in patients with CAO that guarantees the results when applied to this population. The statistics used, Cronbach's α for the reliability analysis, and principal component analysis for the validity are endorsed by the bibliography.…”
Introduction:The aim of this study was to analyse the psychometric performance (reliability and validity) of the TAPQOL questionnaire in measuring the global quality of life in children with central airway obstruction (CAO), which encompasses pathologies with a low prevalence that have a common anatomical or functional affectation.
Method:The study population consisted of 109 patients with CAO attended in a national reference airway unitafter signing informed consent. The TAPQOL questionnaire was used to measure the global quality of life and its psychometric characteristics were analysed. The reliability was determined using Cronbach's α statistic and the validity was determined by means of a principal component analysis.
Results:The mean age was 4.8 years and there was no predominant sex. The most frequent diagnosis was laryngomalacia (24.5%), followed bysubglotticstenosis (20.2%).The lowest score in the TAPQOL questionnaire was obtained for the scales of anxiety (66.2 ± 23.7), respiratory (67.9 ± 29.6), and conduct 68.2 ± 21.4). The Cronbach's α was above 0.7 in the majority of the scales and the validity study by principal component analysis with a total variance of 76.7% fits the original 12-component model.
Conclusions:TAPQOL is a valid tool to measure the health-related quality of life in patients with CAO. Measuring it in these patients indicates which fields are most affected, highlighting therapeutic needs that have not been resolved but which can be approached in normal clinical practice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.